» Authors » Terri Brown-Whitehorn

Terri Brown-Whitehorn

Explore the profile of Terri Brown-Whitehorn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 912
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenhawt M, Albright D, Anvari S, Arends N, Arkwright P, Begin P, et al.
J Allergy Clin Immunol Pract . 2025 Feb; PMID: 39956162
Background: The pivotal phase 3 EPITOPE trial, a 12-month, double-blind, placebo-controlled study of epicutaneous immunotherapy with the VIASKIN patch containing 250 μg of peanut protein (VP250), previously reported significant treatment...
2.
Ackerman K, Gottschalk A, Brown-Whitehorn T
Pediatrics . 2024 Dec; 154(Suppl 4):S20-S21. PMID: 39620803
No abstract available.
3.
Horn S, Brown-Whitehorn T
Pediatrics . 2024 Dec; 154(Suppl 4):S14-S15. PMID: 39620795
No abstract available.
4.
Lucas M, Gabryszewski S, Brown-Whitehorn T
Pediatrics . 2024 Dec; 154(Suppl 4):S13. PMID: 39620777
No abstract available.
5.
Nowak-Wegrzyn A, Sicherer S, Akin C, Anvari S, Bartnikas L, Berin M, et al.
J Allergy Clin Immunol . 2024 Nov; 155(2):336-356. PMID: 39521282
Food protein-induced enterocolitis syndrome (FPIES) is a non-IgE-mediated gastrointestinal food allergy characterized by delayed, protracted vomiting and accompanied by lethargy and pallor, usually 1 to 4 hours after ingesting the...
6.
Brown-Whitehorn T, Spergel J
J Food Allergy . 2024 Jul; 2(1):39-43. PMID: 39022152
Eosinophilic esophagitis (EoE) is a non-immunoglobulin E mediated disorder that has been seen with increasing frequency over the past 25 years. Although the presentation varies per age group from vomiting...
7.
Petroni D, Begin P, Bird J, Brown-Whitehorn T, Chong H, Fleischer D, et al.
JAMA Pediatr . 2024 Feb; 178(4):345-353. PMID: 38407859
Importance: No approved treatment exists for allergen-specific immunoglobulin E (IgE)-mediated cow's milk allergy (CMA), a common childhood food allergy. Objective: To assess dose, efficacy, and safety of epicutaneous immunotherapy with...
8.
Wood R, Togias A, Sicherer S, Shreffler W, Kim E, Jones S, et al.
N Engl J Med . 2024 Feb; 390(10):889-899. PMID: 38407394
Background: Food allergies are common and are associated with substantial morbidity; the only approved treatment is oral immunotherapy for peanut allergy. Methods: In this trial, we assessed whether omalizumab, a...
9.
Kennedy K, Umeweni C, Alston M, Dolinsky L, McCormack S, Taylor L, et al.
Am J Gastroenterol . 2024 Jan; 119(6):1167-1176. PMID: 38235740
Introduction: There are limited data characterizing eating habits among pediatric patients with eosinophilic esophagitis (EoE). We compared eating behaviors in pediatric patients with EoE with healthy controls and assessed the...
10.
Greenhawt M, Sindher S, Wang J, OSullivan M, Du Toit G, Kim E, et al.
N Engl J Med . 2023 May; 388(19):1755-1766. PMID: 37163622
Background: No approved treatment for peanut allergy exists for children younger than 4 years of age, and the efficacy and safety of epicutaneous immunotherapy with a peanut patch in toddlers...